Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial
Article in The Lancet Neurology (May 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in The Lancet Neurology (May 2024)
Article in Cellular and Molecular Life Sciences (April 2024)
Article in Current Treatment Options in Neurology (April 2024)